Design, synthesis, and X-ray crystallographic analysis of a novel class of Hiv-1 protease inhibitors

Ashit K. Ganguly, Sesha S. Alluri, Danielle Caroccia, Dipshikha Biswas, Chih Hung Wang, Eunhee Kang, Yong Zhang, Andrew T. McPhail, Steven S. Carroll, Christine Burlein, Vandna Munshi, Peter Orth, Corey Strickland

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Abstract

In the present paper, design, synthesis, X-ray crystallographic analysis, and HIV-1 protease inhibitory activities of a novel class of compounds are disclosed. Compounds 28-30, 32, 35, and 40 were synthesized and found to be inhibitors of the HIV-1 protease. The crucial step in their synthesis involved an unusual endo radical cyclization process. Absolute stereochemistry of the three asymmetric centers in the above compounds have been established to be (4S,2′R,3′S) for optimal potency. X-ray crystallographic analysis has been used to determine the binding mode of the inhibitors to the HIV-1 protease.

Original languageEnglish
Pages (from-to)7176-7183
Number of pages8
JournalJournal of Medicinal Chemistry
Volume54
Issue number20
DOIs
StatePublished - 27 Oct 2011

Fingerprint

Dive into the research topics of 'Design, synthesis, and X-ray crystallographic analysis of a novel class of Hiv-1 protease inhibitors'. Together they form a unique fingerprint.

Cite this